1. The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer

   • Tsukasa Seya
   • Misako Matsumoto

   Review 31 January 2009 Pages: 1175 - 1184

   

2. Breast cancer cells expressing stem cell markers CD44⁺ CD24^lo are eliminated by Numb-1 peptide-activated T cells

   • Takashi Mine
   • Satoko Matsueda
   • Constantin G. Ioannides

   Original Article 02 December 2008 Pages: 1185 - 1194

   

3. Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγ^null mouse model

   • Asahi Ito
   • Takashi Ishida
   • Ryuzo Ueda

   Original Article Open access 02 December 2008 Pages: 1195 - 1206

   

4. TGF-alpha as a candidate tumor antigen for renal cell carcinomas

   • Sandy Pelletier
   • Simon Tanguay
   • Réjean Lapointe

   Original Article 04 December 2008 Pages: 1207 - 1218

   

5. Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy

   • Robbert G. van der Most
   • Andrew J. Currie
   • Richard A. Lake

   Original Article 04 December 2008 Pages: 1219 - 1228

   

6. A cell-based high-throughput screen to identify synergistic TRAIL sensitizers

   • Nancy Lynn Booth
   • Thomas J. Sayers
   • Curtis J. Henrich

   Original Article 17 December 2008 Pages: 1229 - 1244

   

7. A possible mechanism of intravesical BCG therapy for human bladder carcinoma: involvement of innate effector cells for the inhibition of tumor growth

   • Tomoe Higuchi
   • Masumi Shimizu
   • Hidemi Takahashi

   Original Article Open access 13 January 2009 Pages: 1245 - 1255

   

8. Antigen loading of DCs with irradiated apoptotic tumor cells induces improved anti-tumor immunity compared to other approaches

   • Terry J. Fry
   • Jessica L. Shand
   • Crystal L. Mackall

   Original Article 13 January 2009 Pages: 1257 - 1264

   

9. Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients

   • Valeska Hofmeister-Mueller
   • Claudia S. Vetter-Kauczok
   • Juergen C. Becker

   Original Article Open access 13 January 2009 Pages: 1265 - 1273

   

10. Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis

    • Cai Zhang
    • Yiping Wang
    • Zhigang Tian

    Original Article 13 January 2009 Pages: 1275 - 1285

    

11. Ablation of T cell immunity differentially influences tumor risk in inbred BD rat strains

    • Judith A. M. Marx
    • Ansgar J. Röhrborn
    • Andrea Kindler-Röhrborn

    Original Article 13 January 2009 Pages: 1287 - 1295

    

12. Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases

    • Anna Maria Di Giacomo
    • Riccardo Danielli
    • Michele Maio

    Original Article 13 January 2009 Pages: 1297 - 1306

    

13. Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: immunoadhesins for human IL-10 with therapeutic potential

    • Mizue Terai
    • Yutaka Tamura
    • Takami Sato

    Original Article 14 January 2009 Pages: 1307 - 1317

    

14. Secretion of stress protein grp170 promotes immune-mediated inhibition of murine prostate tumor

    • Ping Gao
    • Xiaolei Sun
    • Xiang-Yang Wang

    Original Article 14 January 2009 Pages: 1319 - 1328

    

15. Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines

    • Adam S. Giermasz
    • Julie A. Urban
    • Pawel Kalinski

    Original Article 21 January 2009 Pages: 1329 - 1336

    

16. Memory and cellular immunity induced by a DNA vaccine encoding self antigen TPD52 administered with soluble GM-CSF

    • Jennifer D. Lewis
    • Laura A. Sullivan
    • Robert K. Bright

    Original Article 24 January 2009 Pages: 1337 - 1349

    

17. Immune-mediated red cell aplasia after anti-CTLA-4 immunotherapy for metastatic melanoma

    • Ilyssa O. Gordon
    • Takisha Wade
    • Thomas F. Gajewski

    Letter to the Editors 04 December 2008 Pages: 1351 - 1353